Addex appoints Graham Dixon CSO
This article was originally published in Scrip
Executive Summary
Addex Therapeutics, a company pioneering allosteric modulation-based oral small molecule drug discovery and development, has made Dr Graham Dixon its first chief scientific officer and head of research. Dr Dixon, who has over 20 years' experience in pharmaceutical research, will report to Dr Bharat Chowrira, CEO of Addex. Dr Dixon most recently served as CSO at Galapagos.